A review of new hormonal therapies for prostate cancer in black men: is there enough data?

Autor: Pascal Blanchet, Thierry Lebret, Matthias E Meunier, Laurent Brureau, Yann Neuzillet

Publikováno v: BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.61. ⟨10.1186/s12885-020-07780-7⟩
BMC Cancer, 2021, 21 (1), pp.61. ⟨10.1186/s12885-020-07780-7⟩
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)

Background Prostate cancer among black men is known to have specific molecular characteristics, especially the androgen receptor or enzymes related to the androgen metabolism. These targets are keys to the action of new hormonal therapies. Neverthele

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af869ac28de170ffd2fa2c172805141b
https://hal.archives-ouvertes.fr/hal-03134963/file/s12885-020-07780-7